Cargando…

A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy

Pancreatic ductal adenocarcinoma (PDA) is a clinically challenging disease with limited treatment options. Despite a small percentage of cases with defective mismatch DNA repair (dMMR), PDA is included in the most immune‐resistant cancer types that are poorly responsive to immune checkpoint blockade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhuolong, Van der Jeught, Kevin, Li, Yujing, Sharma, Samantha, Yu, Tao, Moulana, Ishara, Liu, Sheng, Wan, Jun, Territo, Paul R., Opyrchal, Mateusz, Zhang, Xinna, Wan, Guohui, Lu, Xiongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427404/ https://www.ncbi.nlm.nih.gov/pubmed/37271874 http://dx.doi.org/10.1002/advs.202300548

Ejemplares similares

An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
por: Zhou, Zhuolong, et al.
Publicado: (2021)

Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression?
por: Sharma, Samantha, et al.
Publicado: (2022)

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
por: Li, Yujing, et al.
Publicado: (2018)

Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
por: Xu, Jiangsheng, et al.
Publicado: (2019)

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
por: Sereti, Evangelia, et al.
Publicado: (2023)

Microfluidics guided by deep learning for cancer immunotherapy screening
por: Ao, Zheng, et al.
Publicado: (2022)

Amplification of USP13 drives ovarian cancer metabolism
por: Han, Cecil, et al.
Publicado: (2016)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

N(6)-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
por: Niu, Yi, et al.
Publicado: (2018)

RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer
por: Sun, Lei, et al.
Publicado: (2021)

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
por: Liu, Yunhua, et al.
Publicado: (2018)

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy
por: Alhallak, Kinan, et al.
Publicado: (2021)

Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening
por: Geyer, Marlene, et al.
Publicado: (2021)

A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options
por: Sun, Lulu, et al.
Publicado: (2023)

An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity
por: Jiang, Shengwei, et al.
Publicado: (2020)

Organoid Models for Precision Cancer Immunotherapy
por: Sun, Cai-Ping, et al.
Publicado: (2022)

Emerging liver organoid platforms and technologies
por: Lam, Do Thuy Uyen Ha, et al.
Publicado: (2021)

A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer
por: Mainardi, Sara, et al.
Publicado: (2022)

Engineering Microfluidic Organoid-on-a-Chip Platforms
por: Yu, Fang, et al.
Publicado: (2019)

Cerebral Organoids as an Experimental Platform for Human Neurogenomics
por: Nowakowski, Tomasz J., et al.
Publicado: (2022)

Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
por: Watanabe, Sadanori, et al.
Publicado: (2022)

3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
por: Kang, Ya’an, et al.
Publicado: (2022)

The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19
por: Geurts, Maarten H., et al.
Publicado: (2021)

The Immunoreactive Platform of the Pancreatic Islets Influences the Development of Autoreactivity
por: Unanue, Emil R., et al.
Publicado: (2019)

OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics
por: Matthews, Jonathan M., et al.
Publicado: (2022)

Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer
por: Moreira, Leticia, et al.
Publicado: (2017)

Generation of Pancreatic Organoid-Derived Isografts
por: D’Agosto, Sabrina, et al.
Publicado: (2020)

Application of organoids in precision immunotherapy of lung cancer (Review)
por: Tian, Huichuan, et al.
Publicado: (2023)

Breast cancer organoids and their applications for precision cancer immunotherapy
por: Guan, Dandan, et al.
Publicado: (2023)

Editorial: Novel signaling pathways and therapy in breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2023)

Organoids as a Systems Platform for SCLC Brain Metastasis
por: Quaranta, Vito, et al.
Publicado: (2022)

Tumor organoid biobank-new platform for medical research
por: Xie, Xuexue, et al.
Publicado: (2023)

Cancer organoids: A platform in basic and translational research
por: Ma, Xin, et al.
Publicado: (2023)

Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
por: Li, Yongjiang, et al.
Publicado: (2022)

MODL-28. Patient-derived, three-dimensional organoid platform for pediatric brain tumor modeling
por: Baubet, Valerie, et al.
Publicado: (2022)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
por: Klein, Eliane, et al.
Publicado: (2020)

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies
por: Ou, Lingling, et al.
Publicado: (2023)

3-D retina organoids: Building platforms for therapies of the future
por: Mazerik, Jessica N, et al.
Publicado: (2018)

Human Organoids as a Promising Platform for Fighting COVID-19
por: Chen, Dong, et al.
Publicado: (2022)

Organoid and microfluidics-based platforms for drug screening in COVID-19
por: Ramezankhani, Roya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qs5vi6t46eunkpk4ucfpibisaj